BRKR Financials: Bruker Corp AI Analysis



Financials

BRKR Financial

Bruker Corp

$62.69

9.4%

$5.39

At close: Jun 03, 16:00:00 GMT-4

$62.7

0.01%

$0.01

Post-market: Jun 03, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$57.3

Open

$57.49

Day's Range

$56.59 - $63.01

52 week range

$28.53 - $62.7

Volume

4.3M

Avg.Volume

2.3M

Dividend yield

0.65%

EPS (TTM)

-0.08

Market Cap

$9.5B

What is BRKR?

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,396 full-time employees. The company went IPO on 2000-08-04. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.

Features

Markets

News

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
Revenue	3,458	823	977	860	797	801
Revenue Growth (YoY)	0%	3%	0%	0%	0%	11%
Cost of Revenue	1,843	434	513	460	435	407
Gross Profit	1,615	389	464	399	362	393
Selling, General & Admin	963	242	247	242	231	225
Research & Development	399	101	99	98	100	97
Operating Expenses	1,368	344	347	342	333	324
Other Non Operating Income (Expenses)	17	15	-1	3	0	0
Pretax Income	18	21	68	-71	0	25
Income Tax Expense	23	2	37	-14	-3	8
Net Income	-36	3	14	-62	7	17
Net Income Growth	-146%	-82%	8%	-254.99%	0%	-66%
Shares Outstanding (Diluted)	152.7	152.7	152.1	151.8	151.7	151.9
Shares Change (YoY)	1%	1%	0%	0%	3%	4%
EPS (Diluted)	-0.24	0.02	0.09	-0.41	0.05	0.11
EPS Growth	-146%	-80%	9%	-252.99%	-3%	-67%
Free Cash Flow	22	47	178	-54	-148	39
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	46.7%	47.26%	47.49%	46.39%	45.42%	49.06%
Operating Margin	7.11%	5.46%	11.87%	6.51%	3.51%	8.61%
Profit Margin	-1.04%	0.36%	1.43%	-7.2%	0.87%	2.12%
Free Cash Flow Margin	0.63%	5.71%	18.21%	-6.27%	-18.56%	4.86%
EBITDA	474	103	174	111	84	119
EBITDA Margin	13.7%	12.51%	17.8%	12.9%	10.53%	14.85%
D&A For EBITDA	228	58	58	55	56	50
EBIT	246	45	116	56	28	69
EBIT Margin	7.11%	5.46%	11.87%	6.51%	3.51%	8.61%
Effective Tax Rate	127.77%	9.52%	54.41%	19.71%	0%	32%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

Revenue

3,458

823

977

860

797

801

Revenue Growth (YoY)

11%

Cost of Revenue

1,843

434

513

460

435

407

Gross Profit

1,615

389

464

399

362

393

Selling, General & Admin

963

242

247

242

231

225

Research & Development

399

101

100

Operating Expenses

1,368

344

347

342

333

324

Other Non Operating Income (Expenses)

-1

Pretax Income

-71

Income Tax Expense

-14

-3

Net Income

-36

-62

Net Income Growth

-146%

-82%

-254.99%

-66%

Shares Outstanding (Diluted)

152.7

152.1

151.8

151.7

151.9

Shares Change (YoY)

EPS (Diluted)

-0.24

0.02

0.09

-0.41

0.05

0.11

EPS Growth

-146%

-80%

-252.99%

-3%

-67%

Free Cash Flow

178

-54

-148

Free Cash Flow Per Share

Gross Margin

46.7%

47.26%

47.49%

46.39%

45.42%

49.06%

Operating Margin

7.11%

5.46%

11.87%

6.51%

3.51%

8.61%

Profit Margin

-1.04%

0.36%

1.43%

-7.2%

0.87%

2.12%

Free Cash Flow Margin

0.63%

5.71%

18.21%

-6.27%

-18.56%

4.86%

EBITDA

474

103

174

111

119

EBITDA Margin

13.7%

12.51%

17.8%

12.9%

10.53%

14.85%

D&A For EBITDA

228

EBIT

246

116

EBIT Margin

7.11%

5.46%

11.87%

6.51%

3.51%

8.61%

Effective Tax Rate

127.77%

9.52%

54.41%

19.71%

32%

Follow-Up Questions

What are Bruker Corp's key financial statements?



According to the latest financial statement (Form-10K), Bruker Corp has a total asset of $0, Net loss of $0

What are the key financial ratios for BRKR?



Bruker Corp's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Bruker Corp's revenue broken down by segment or geography?



Bruker Corp largest revenue segment is Total BSI, at a revenue of 1,492,600,000 in the most earnings release.For geography, United States is the primary market for Bruker Corp, at a revenue of 891,300,000.

Is Bruker Corp profitable?



no, according to the latest financial statements, Bruker Corp has a net loss of $0

Does Bruker Corp have any liabilities?



no, Bruker Corp has liability of 0

How many outstanding shares for Bruker Corp?



Bruker Corp has a total outstanding shares of 0

Bruker Corp (BRKR) Financial

BRKR Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is BRKR?

Bruker Corp (BRKR) Financial

BRKR Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is BRKR?

BRKR Income

Follow-Up Questions

What are Bruker Corp's key financial statements?

What are the key financial ratios for BRKR?

How is Bruker Corp's revenue broken down by segment or geography?

Is Bruker Corp profitable?

Does Bruker Corp have any liabilities?

How many outstanding shares for Bruker Corp?